id	sid	eid	entity	type
ffhd-1330	1	1	12-week	DATE
ffhd-1330	1	2	japanese	NORP
ffhd-1330	1	3	2160-3855	CARDINAL
ffhd-1330	1	4	issn	PERSON
ffhd-1330	1	5	2378-7007	DATE
ffhd-1330	1	6	2160-3855	CARDINAL
ffhd-1330	1	7	issn	PERSON
ffhd-1330	1	8	2378-7007	DATE
ffhd-1330	2	1	14 no. 6	CARDINAL
ffhd-1330	2	2	2024): june 2024	DATE
ffhd-1330	2	3	12-week	DATE
ffhd-1330	2	4	japanese	NORP
ffhd-1330	2	5	kuwabara yoshitaka	PERSON
ffhd-1330	2	6	lee akiko hirose	PERSON
ffhd-1330	2	7	yuji makino kyohei	PERSON
ffhd-1330	2	8	sakata tadashi watanabe doi:	PERSON
ffhd-1330	2	9	https://doi.org/10.31989/ffhd.v14i6.1330	CARDINAL
ffhd-1330	3	1	85.2-fold	CARDINAL
ffhd-1330	4	1	ninety	CARDINAL
ffhd-1330	4	2	japanese	NORP
ffhd-1330	4	3	150 mg	QUANTITY
ffhd-1330	4	4	12 weeks	DATE
ffhd-1330	5	1	second	ORDINAL
ffhd-1330	5	2	poms2	PERSON
ffhd-1330	5	3	every 4 weeks	DATE
ffhd-1330	7	1	poms2	PERSON
ffhd-1330	7	2	40	DATE
ffhd-1330	7	3	week 12	DATE
ffhd-1330	11	1	12 weeks	DATE
ffhd-1330	12	1	umin000050377	ORG
ffhd-1330	12	2	theracurmin	ORG
ffhd-1330	14	1	2024	CARDINAL
ffhd-1330	15	1	14	CARDINAL
ffhd-1330	15	2	6	CARDINAL
ffhd-1330	15	3	2024): june 2024	DATE
ffhd-1330	15	4	2024	CARDINAL
ffhd-1330	15	5	4.0	CARDINAL
ffhd-1330	16	1	ffc	ORG
ffhd-1330	16	2	first	ORDINAL
ffhd-1330	16	3	4.0	CARDINAL